IP35-15: Molecular characterization and a showcase clinical study on treatment de-escalation for luminal favorable muscle-invasive bladder cancer

IP35-15: Molecular characterization and a showcase clinical study on treatment de-escalation for luminal favorable muscle-invasive bladder cancer

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!